Related Experiment Videos

Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM)

A Yoshioka1, G Hirose, Y Ueda

  • 1Department of Neurology, Kanazawa Medical University, Ishikawa, Japan.

Insights

Early stage HTLV-I-associated myelopathy (HAM) shows spinal cord damage with myelin and axon loss. Predominant CD8+ T cell infiltration, not HTLV-I antigens, indicates key neuropathology.

Area of Science:

  • Neuropathology
  • Immunology
  • Neurovirology

Background:

  • Human T-lymphotropic virus type I (HTLV-I) infection can lead to HTLV-I-associated myelopathy (HAM), a neurodegenerative disease.
  • Understanding the early neuropathological changes in HAM is crucial for potential therapeutic interventions.

Observation:

  • Necropsy of a patient with 9-month clinical duration HAM revealed significant spinal cord pathology.
  • Lesions were observed in the lateral and posterior columns, extending from cervical to lumbar regions.
  • Prominent vacuolar changes, indicative of myelin sheath splitting, were noted.

Findings:

  • Microscopic examination showed loss of myelin sheaths and axons.
  • Perivascular lymphocytic infiltration was a consistent finding.
  • Immunohistochemistry revealed a predominance of CD8+ cytotoxic T cells in the brain and spinal cord.
  • Importantly, HTLV-I core protein antigen-bearing cells were absent in the central nervous system examined.

Implications:

  • These findings suggest that myelin sheath damage and CD8+ cytotoxic T cell infiltration are primary neuropathological features in early-stage HAM.
  • The absence of HTLV-I antigens within the CNS lesions points towards an immune-mediated mechanism rather than direct viral cytopathicity.
  • This highlights the importance of the host immune response in the pathogenesis of HAM.

Related Concept Videos